Literature DB >> 19012132

Pharmacotherapy for schizophrenic inpatients in East Asia--changes and challenges.

Naotaka Shinfuku1, Chay-Hoon Tan.   

Abstract

OBJECTIVES: (1) to review characteristics of prescription patterns of antipsychotic medication in China, Hong Kong, Japan, Korea, Singapore and Taiwan, (2) to examine the changes of prescriptions brought about by the introduction of second generation psychotropic drugs (SGA) in East Asia, (3) to analyse factors contributing to the characteristic use of antipsychotics, and (4) to suggest ways and means to improve the prescription practice of antipsychotics in East Asia.
METHODS: Authors of this study collaborated with psychiatrists in East Asia to undertake an international survey reviewing prescription patterns of psychotropic medications in East Asia. The REAP (Research on Asian psychotropic prescription patterns) study reviewed the prescription of a large number of schizophrenic inpatients in China, Hong Kong, Japan, Korea, Singapore and Taiwan in 2001 and 2004 using a unified research protocol and questionnaire.
RESULTS: Prescription patterns of antipsychotic drugs differ greatly country by country and have recently experienced rapid changes. Our survey shows second generation antipsychotics are frequently used in East Asia. The introduction of SGA resulted in the combined use of first generation psychotropic drugs (FGA) and SGA in East Asia. These changing prescription patterns have created many challenges for psychiatrists in East Asia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19012132     DOI: 10.1080/09540260802397560

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  12 in total

1.  Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia.

Authors:  Y-T Xiang; G S Ungvari; C U Correll; H F K Chiu; N Shinfuku
Journal:  Epidemiol Psychiatr Sci       Date:  2015-08-20       Impact factor: 6.892

2.  Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database.

Authors:  Yoko Hirano; Yoichi Ii
Journal:  Clin Drug Investig       Date:  2019-11       Impact factor: 2.859

3.  Analysis of the trends of polypharmacy and high-dose prescriptions in Japan.

Authors:  Naotaka Shinfuku
Journal:  Asia Pac Psychiatry       Date:  2021-09-14       Impact factor: 3.788

4.  Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence.

Authors:  Katarina Kelin; Alan Jm Brnabic; Richard Newton; Raúl I Escamilla; Liang-Jen Chuo; Malina Simu; Wenyu Ye; William Montgomery; Jamie Karagianis; Haya Ascher-Svanum
Journal:  Patient Prefer Adherence       Date:  2010-09-07       Impact factor: 2.711

5.  Antipsychotics prescribing patterns of patients with schizophrenia admitted to korean general hospital psychiatric unit: 2001 to 2008.

Authors:  Hye Jin Choi; Seung Ho Jung; Min Hee Kang; Jeong Seop Lee; Jae Nam Bae; Chul Eung Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-04-30       Impact factor: 2.582

6.  Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan.

Authors:  Wenyu Ye; Haya Ascher-Svanum; Yuka Tanji; Jennifer A Flynn; Michihiro Takahashi
Journal:  Patient Prefer Adherence       Date:  2011-12-14       Impact factor: 2.711

7.  Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan.

Authors:  Wenyu Ye; Haya Ascher-Svanum; Jennifer A Flynn; Yuka Tanji; Michihiro Takahashi
Journal:  Clinicoecon Outcomes Res       Date:  2012-01-13

8.  Use of clozapine in older Asian patients with schizophrenia between 2001 and 2009.

Authors:  Yu-Tao Xiang; Robert W Buchanan; Gabor S Ungvari; Helen F K Chiu; Kelly Y C Lai; You-Hong Li; Tian-Mei Si; Chuan-Yue Wang; Edwin H M Lee; Yan-Ling He; Shu-Yu Yang; Mian-Yoon Chong; Ee-Heok Kua; Senta Fujii; Kang Sim; Michael K H Yong; Jitendra K Trivedi; Eun-Kee Chung; Pichet Udomratn; Kok-Yoon Chee; Norman Sartorius; Chay-Hoon Tan; Naotaka Shinfuku
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

9.  Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis.

Authors:  Wenyu Ye; Haya Ascher-Svanum; Yuka Tanji; Jennifer A Flynn; Michihiro Takahashi; Robert R Conley
Journal:  Neuropsychiatr Dis Treat       Date:  2012-06-18       Impact factor: 2.570

10.  Prescription patterns for patients with schizophrenia in Korea: a focus on antipsychotic polypharmacy.

Authors:  Hee-Yun Kim; Hee-Won Lee; Seung-Ho Jung; Min-Hee Kang; Jae-Nam Bae; Jeong-Seop Lee; Chul-Eung Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-08-12       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.